午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
Guangzhou Viocon Pharmaceutical Technology Co., Ltd
Firmenname:
Guangzhou Viocon Pharmaceutical Technology Co., Ltd
Telefon:
-
E-Mail:
pengguizi@cti-cert.com
Nationalit?t:
China
URL:
Produkte insgesamt:
381
1
2
3
4
Produktkatalog
N-Nitroso desmethyl Bedaquiline
(R,S)-N-NITROSOANABASINE
37620-20-5
C10H13N3O
N-Nitroso desmethyl Amitriptyline
55855-42-0
C19H20N2O
N-Nitroso Bendroflumethiazide
N-Nitroso Benzonatate
N-Nitroso Belumosudil
Benzenebutanoic acid, γ-cyano-3,4-dimethoxy-γ-(1-methylethyl)-, (γS)-, compd. with (αR)-α-methylbenzenemethanamine (1:1)
194854-18-7
C16H21NO4.C8H11N
N-Nitroso Acebutolol
N-Nitroso Avacopan
N-Nitroso Amoxapine
N-Nitroso Albuterol
2919946-71-5
C13H20N2O4
N-Nitroso desmethyl Almotriptan
N-Nitroso Avanafil
N-Nitroso Argatroban
Ruxolitinib
941678-49-5
C17H18N6
2-bromo-3-methylpropiophenone
1451-83-8
C10H11BrO
2-(Cyclohept-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
287944-13-2
C13H23BO2
Crizotinib
877399-52-5
C21H22Cl2FN5O
tert-Butyl (2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)carbamate
1231755-15-9
C9H15F3N2O3
Sunitinib Malate
341031-54-7
C26H33FN4O7
1-methyl-1H-imidazole-5-boronic acid pinacol este
942070-72-6
C10H17BN2O2
2-Amino-1-morpholinoethanone
56414-96-1
C6H12N2O2
Erlotinib hydrochloride
183319-69-9
C22H24ClN3O4
Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, anhydride with 2-methylpropyl hydrogen carbonate
66866-43-1
C12H21NO6
lenvatinib Mesylate
857890-39-2
C22H23ClN4O7S
N-Nitroso tadalafil
Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate
518990-21-1
C9H12N2O3
2,6-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
939968-08-8
C12H16BF2NO2
Sorafenib tosylate
475207-59-1
C21H16ClF3N4O3.C7H8O3S
GSK1120212 (DMSO solvate)
1187431-43-1
C28H29FIN5O5S
Crizotinib Impurity 03
1801651-84-2
C21H23ClFN5O
Trametinib Impurity 13
871700-32-2
C25H21FIN3O6S
Dasatinib Impurity 1
Ibubinib impurity 07
1839099-22-7
C25H26N6O2
Trametinib Impurity 20
871701-23-4
C26H23FIN5O4
Trametinib Impurity 17
871700-65-1
C26H24FN5O4
Ibubinib impurity 02
936563-96-1
C25H24N6O2
Trametinib Impurity 11
871700-25-3
C26H23FIN5O4
Crizotinib Impurity10
1374356-45-2
C21H22Cl2FN5O
Ibubinib impurity 04
2031255-23-7
C50H48N12O4
Crizotinib Impurity09
1428476-77-0
C23H26Cl2FN5O
Trametinib Impurity 19
3018911-27-5
C17H17FIN3O3
Ruxolitinib Impurity4
41685-37-6
C18H20N6O
Ibubinib impurity 06
1288338-95-3
C24H24N6O2
Trametinib Impurity 21
871701-87-0
C24H21FIN5O3
Pomalidomide
19171-19-8
C13H11N3O4
Palbociclib Impurity
C22H28ClN7O
LenalidoMide
191732-72-6
C13H13N3O3
Trametinib Impurity 02
871700-28-6
C13H11FIN3O2
Dasatinib
302962-49-8
C22H26ClN7O2S
Crizotinib Impurity 04
3026867-46-6
C16H13Cl2FN4O
Trametinib Impurity 03
871700-30-0
C16H16FIN4O2
Ibrutinib Impurity
2417548-76-4
C50H48N12O4
Ibubinib impurity 03
1987905-93-0
C47H46N12O3
Ruxolitinib Impurity2
Crizotinib Impurity05
2925080-43-7
C23H24Cl2FN5O2
Imatinib mesylate
220127-57-1
C30H35N7O4S
Ibubinib impurity 12
936563-92-7
C25H24N6O2
Trametinib Impurity 15
329941-39-1
C15H16N2O3S
1-(2-Hydroxyethyl)piperazine
2-Piperazin-1-ylethanol
103-76-4
C6H14N2O
Nilotinib Hydrochloride
923288-95-3
C28H23ClF3N7O
Ibubinib impurity 08
2031255-26-0
C26H28N6O3
Atrasentan Impurity 05
Palbociclib Impurity02
851067-56-6
C22H26BrN7O
Palbociclib Impurity03
2174002-16-3
C25H29N7O3
Palbociclib Impurity11
1311611-88-7
C16H24N4O3
Dasatinib Impurity01
910297-51-7
C20H22ClN7OS
Palbociclib Impurity04
571189-64-5
C15H18N4O2
Palbociclib Impurity1
808142-23-6
C36H28O3P2
Dasatinib Impurity07
1245157-42-9
C15H20N6O3S
Ruxolitinib Impurity 30
2606144-45-8
C16H18N6O
Dasatinib Impurity04
2099694-53-6
C18H24ClN5O
Ruxolitinib Impurity12
3016399-18-8
Dasatinib Impurity12
1780-26-3
C5H4Cl2N2
Palbociclib Impurity07
1415560-29-0
C13H13Br2N3O
Atrasentan Impurity 04
Dasatinib Impurity03
910297-61-9
C36H34Cl2N12O2S2
Palbociclib Impurity12
1922954-32-2
C13H14BrN3O2
Atrasentan Impurity 07
Palbociclib Impurity08
1023594-49-1
C14H22N4O2
Palbociclib Impurity15
2204368-66-9
C24H29N7O2
Dasatinib Impurity10
302964-08-5
C16H13Cl2N5OS
Palbociclib Impurit 01
571190-22-2
C22H27N7O
Ruxolitinib Impurity 05
2102675-40-9
C17H19N5O2
Atrasentan Impurity 01
C29H38N2O6
Dasatinib Impurity09
302964-24-5
C11H10ClN3OS
Dasatinib Impurity02
910297-52-8
C22H26ClN7O3S
Atrasentan Impurity 03
Ruxolitinib Impurity 04
1911644-32-0
C17H20N6O
Ruxolitinib Impurity 01
952518-97-7
C9H7N5
Palbociclib Impurity09
2144748-14-9
C14H18N6
Ruxolitinib Impurity 08
2703484-89-1
C17H18N6.H3O4P
Dasatinib Impurity08
1184919-23-0
C22H27N7O2S
Palbociclib Impurity14
1941177-45-2
C29H37N7O3
Ruxolitinib Impurity 02
2606144-44-7
C16H18N6O2
Ruxolitinib Impurity 06
3027185-21-0
C25H29N7
Dasatinib Impurity11
863127-76-8
C12H14ClNO2
Ruxolitinib Impurity11
2231734-31-7
Palbociclib Impurity05
571189-65-6
C27H35N7O3
Ruxolitinib Impurity10
1792190-52-3
C25H18ClN3
1
2
3
4
Copyright 2019 ? ChemicalBook. All rights reserved